These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10417841)

  • 1. Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid.
    Behrens S; Grundmann-Kollmann M; Peter RU; Kerscher M
    Br J Dermatol; 1999 Jul; 141(1):177. PubMed ID: 10417841
    [No Abstract]   [Full Text] [Related]  

  • 2. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
    Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
    Dando TM; Wellington K
    Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tazarotene in combination with phototherapy.
    Koo JY
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S144-8. PubMed ID: 9777793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A; Seeber A
    Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
    Green L; Sadoff W
    J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene in combination with topical corticosteroids.
    Lebwohl M; Poulin Y
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing treatment with topical tazarotene.
    Guenther LC
    Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis: current perspectives with an emphasis on treatment.
    Linden KG; Weinstein GD
    Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tazarotene combination treatments in psoriasis.
    Guenther L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S36-42. PubMed ID: 10898828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis.
    Muchenberger S; Schöpf E; Simon JC
    Br J Dermatol; 1997 Oct; 137(4):587-9. PubMed ID: 9390336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising the use of tazarotene in clinical practice: consensus statement from the European advisory panel for tazarotene (Zorac TM).
    Gollnick HP; Finzi AF; Marks R; Barker JN; Jansen C; Revuz J; Saurat J
    Dermatology; 1999; 199(1):40-6. PubMed ID: 10449956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical agents for the treatment of psoriasis, past, present and future.
    Tremblay JF; Bissonnette R
    J Cutan Med Surg; 2002; 6(3 Suppl):8-11. PubMed ID: 11976984
    [No Abstract]   [Full Text] [Related]  

  • 14. Tazarotene--a topical retinoid for psoriasis.
    Drug Ther Bull; 1999 Jun; 37(6):47-8. PubMed ID: 10692712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obtaining the optimal treatment outcome with tazarotene.
    McClelland PB
    Dermatol Nurs; 1998 Oct; 10(5):343-8. PubMed ID: 9873273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new retinoids for psoriasis.
    Med Lett Drugs Ther; 1997 Nov; 39(1013):105-6. PubMed ID: 9391501
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of topical tazarotene in the treatment of congenital ichthyoses.
    Hofmann B; Stege H; Ruzicka T; Lehmann P
    Br J Dermatol; 1999 Oct; 141(4):642-6. PubMed ID: 10583110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear Darier's disease successfully treated with 0.1% tazarotene gel "short-contact" therapy.
    Brazzelli V; Prestinari F; Barbagallo T; Vassallo C; Agozzino M; Borroni G
    Eur J Dermatol; 2006; 16(1):59-61. PubMed ID: 16436344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP.
    Ettler K; Richards B
    Int J Dermatol; 2001 Aug; 40(8):541-2. PubMed ID: 11703532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.